Chicago Equity Partners LLC raised its stake in Cigna Corporation (NYSE:CI) by 51.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,390 shares of the health services provider’s stock after purchasing an additional 810 shares during the period. Chicago Equity Partners LLC’s holdings in Cigna Corporation were worth $447,000 as of its most recent SEC filing.

A number of other institutional investors also recently made changes to their positions in the business. Capstone Investment Advisors Netherlands B.V. purchased a new position in shares of Cigna Corporation during the second quarter worth approximately $106,000. Saratoga Research & Investment Management purchased a new position in shares of Cigna Corporation during the third quarter worth approximately $112,000. Parallel Advisors LLC grew its position in shares of Cigna Corporation by 62.3% during the second quarter. Parallel Advisors LLC now owns 800 shares of the health services provider’s stock worth $139,000 after acquiring an additional 307 shares during the last quarter. Acrospire Investment Management LLC grew its position in shares of Cigna Corporation by 66.7% during the second quarter. Acrospire Investment Management LLC now owns 1,000 shares of the health services provider’s stock worth $167,000 after acquiring an additional 400 shares during the last quarter. Finally, Financial Architects Inc grew its position in shares of Cigna Corporation by 186.0% during the second quarter. Financial Architects Inc now owns 1,121 shares of the health services provider’s stock worth $188,000 after acquiring an additional 729 shares during the last quarter. Institutional investors own 89.69% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This story was originally posted by Watch List News and is owned by of Watch List News. If you are accessing this story on another site, it was stolen and republished in violation of U.S. & international copyright legislation. The legal version of this story can be read at https://www.watchlistnews.com/cigna-corporation-ci-holdings-boosted-by-chicago-equity-partners-llc/1711506.html.

In other news, insider Michael W. Triplett sold 10,417 shares of Cigna Corporation stock in a transaction on Monday, November 13th. The stock was sold at an average price of $197.77, for a total transaction of $2,060,170.09. Following the completion of the transaction, the insider now owns 32,347 shares of the company’s stock, valued at approximately $6,397,266.19. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CAO Mary T. Hoeltzel sold 575 shares of Cigna Corporation stock in a transaction on Thursday, November 9th. The stock was sold at an average price of $197.03, for a total value of $113,292.25. Following the transaction, the chief accounting officer now directly owns 2,499 shares of the company’s stock, valued at approximately $492,377.97. The disclosure for this sale can be found here. In the last three months, insiders sold 12,471 shares of company stock valued at $2,449,891. 1.30% of the stock is owned by corporate insiders.

A number of equities analysts have recently issued reports on CI shares. Royal Bank Of Canada restated a “buy” rating and set a $182.00 target price on shares of Cigna Corporation in a research report on Monday, July 24th. ValuEngine raised Cigna Corporation from a “hold” rating to a “buy” rating in a report on Wednesday, July 26th. Piper Jaffray Companies reaffirmed a “buy” rating and set a $175.00 price target on shares of Cigna Corporation in a report on Friday, July 28th. BidaskClub downgraded Cigna Corporation from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Finally, Jefferies Group LLC reaffirmed a “buy” rating and set a $190.00 price target (down from $199.00) on shares of Cigna Corporation in a report on Friday, August 4th. Three equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $201.50.

Shares of Cigna Corporation (CI) opened at $197.97 on Friday. Cigna Corporation has a fifty-two week low of $131.03 and a fifty-two week high of $206.45. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.39 and a quick ratio of 0.39. The company has a market capitalization of $49,550.00, a price-to-earnings ratio of 18.99, a price-to-earnings-growth ratio of 1.51 and a beta of 0.49.

Cigna Corporation (NYSE:CI) last released its earnings results on Thursday, November 2nd. The health services provider reported $2.83 EPS for the quarter, beating analysts’ consensus estimates of $2.36 by $0.47. Cigna Corporation had a return on equity of 18.85% and a net margin of 5.74%. The company had revenue of $10.38 billion during the quarter, compared to the consensus estimate of $10.17 billion. During the same quarter last year, the company earned $1.94 earnings per share. Cigna Corporation’s quarterly revenue was up 5.1% compared to the same quarter last year. equities research analysts expect that Cigna Corporation will post 10.34 EPS for the current year.

Cigna Corporation Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Institutional Ownership by Quarter for Cigna Corporation (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.